Medizone Intl. (fka MZEIQ)

[never-say-die]

The problem may be huge and solutions needed urgently but so far no one is looking to ASure.

We have had regulatory approval in Canada and New Zealand for well over two years and not a single bite. Not a single sale or service contract announced over a wide range of potential users.

Canada is the home turf of our two doctors and the only action they have been able to generate there is to handle a one shot emergency situation in a hospital they control. There hasn't even been an announcement that ASure was incorporated into their regular routine or even sign up for a service contract.

New Zealand is still a complete zero with the excuse that despite complete regulatory approval there, customers are willing to wait indefinitely to see USA EPA approval before they will buy. I can't imagine every industry, large and small across the board sitting on their thumbs waiting for EPA approval they don't even require if they see an urgent need and the potential benefits of ASure.

It should be obvious to everyone that there are serious roadblocks to marketing ASure. What the problems are is anybody's guess. It's clear the company will not address the issue publically.

Most posters here think EPA approval is the magic bullet that's going to see this product take off.

Don't count on it until they overcome the obstacles in their existing markets. It's not going to be any different here.